Table S1 - Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids

Plasma glucose, lipid and phybrid concentrations following sustained administration of AC164204, AC164209, exenatide, and/or davalintide in DIO rats. Glucose, triglycerides, total cholesterol and HDL cholesterol were measured after 28 days of sustained infusion. Groups not sharing a superscript are significantly different from one another (p (DOCX)本数据集记录了在饮食诱导肥胖（Diet-Induced Obesity, DIO）大鼠中持续给予AC164204、AC164209、艾塞那肽（exenatide）及/或达伐林肽（davalintide）后的血浆葡萄糖、脂质及杂合浓度。在持续输注28天后，对葡萄糖、甘油三酯、总胆固醇及高密度脂蛋白胆固醇（HDL cholesterol）进行了检测。无共同上标的组间差异具有统计学意义（p相关标注未完整呈现）。